Understanding malaria across Burkina Faso
Official title: Burkina Faso ICEMR
Funded at Colorado State University · NIH-11512411 · Data updated 2026-11-12
Researchers will collect information from people, parasites, and mosquitoes in different parts of Burkina Faso to help improve malaria prevention and treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colorado State University NIH-funded |
| Lab location | 1 site (Fort Collins, United States) |
| Project start | April 26, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $245,008 |
| NIH project number | 3U19AI181595-03S1 |
| Project ID | NIH-11512411 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living in the selected sites of Burkina Faso—including children and adults in urban, rural, and migrant/gold-mining communities—who have or are at risk for malaria.
✕Less likely to help
People outside the study areas in Burkina Faso or those with illnesses unrelated to malaria are unlikely to directly benefit from participation.
What this research studies
This project brings local and international teams into urban, rural, and migrant/gold-mining communities across Burkina Faso to collect blood samples, clinical information, and mosquito data. Teams will identify parasite species and genetics, record who gets sick by age and clinical status, and map the mosquito species found near permanent and temporary water sources. Laboratory work will test parasites and mosquitoes for drug and insecticide resistance and study how well mosquitoes pass on infection. All clinical and field data will be combined into a central database and the project will build local lab and data-management capacity.
Why it matters
Potential benefit: If successful, the work could help target prevention and treatment where they are most needed and reduce malaria in affected communities.
How similar studies have gone: Other integrated malaria surveillance and vector studies have helped guide control programs, though combining genetics, vector, and human data across many landscapes at this scale is ambitious and partly novel.
Where this research is happening
-
Colorado State University
Fort Collins, United States Active
Researchers
- Principal investigator: Foy, Brian David — Colorado State University
- Study coordinator: Foy, Brian David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.